Brief: Rubius Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results

Rubius Therapeutics

25/02/2022 13:24

Feb 25 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * Q4 LOSS PER SHARE $0.61
    * RUBIUS THERAPEUTICS - AS OF DEC 31, 2021, CASH, CASH
EQUIVALENTS
OF $225.8 MILLION PROVIDING CO CASH RUNWAY INTO Q2 2023
    * AS OF DEC 31, 2021, CASH AND CASH EQUIVALENTS PROVIDES
RUBIUS
ABILITY TO EXTEND RUNWAY INTO MIDDLE OF 2023
    * Q4 EARNINGS PER SHARE VIEW $-0.59 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXZ0qTw 
Further company coverage:  RUBY.O 

 ((reuters.briefs@thomsonreuters.com;))